Effect of a Single High Loading Dose of Rosuvastatin on Percutaneous Coronary Intervention for Acute Coronary Syndromes

Conclusions:
A single, high dose (20 mg) of rosuvastatin prior to PCI reduces postprocedural myocardial injury in patients with ACS, with a concomitant attenuation of the postprocedural increase in hs-CRP and IL-6 levels.

Source: Journal of Cardiovascular Pharmacology and Therapeutics - June 12, 2013 Category: Cardiology Authors: Wang, Z., Dai, H., Xing, M., Yu, Z., Lin, X., Wang, S., Zhang, J., Hou, F., Ma, Y., Ren, Y., Tan, K., Wang, Y., Ge, Z. Tags: Clinical Studies Source Type: research